Drugs / 3% Sodium Chloride
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03677310 | Apr 2018 → Nov 2019 | — | University of Missouri-Columbia | Withdrawn | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02233985 | Aug 2013 → Feb 2017 | acute bronchiolitis, asthma | Coordinación de Investigación en Salud, Mexico | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3% Sodium Chloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02233985 ↗ |
| Route | Inhaled | “nebulized” NCT02233985 ↗ |